# Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery

> **NCT03799133** · NA · COMPLETED · sponsor: **Critical Perfusion Inc.** · enrollment: 38 (actual)

## Conditions studied

- Cardiac Failure
- Ventricular Dysfunction
- Valvular Heart Disease

## Interventions

- **DEVICE:** Florence device

## Key facts

- **NCT ID:** NCT03799133
- **Lead sponsor:** Critical Perfusion Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-26
- **Primary completion:** 2019-12-28
- **Final completion:** 2019-12-28
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2020-01-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03799133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03799133, "Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03799133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*